Results 241 to 250 of about 129,945 (312)
The PI3Kδ inhibitor roginolisib (IOA‐244) preserves T‐cell function and activity
Identification of novel PI3K inhibitors with limited immune‐related adverse effects is highly sought after. We found that roginolisib and idelalisib inhibit chronic lymphocytic leukemia (CLL) cells and Treg suppressive functions to similar extents, but roginolisib affects cytotoxic T‐cell function and promotion of pro‐inflammatory T helper subsets to a
Elise Solli +7 more
wiley +1 more source
ITCH regulates Golgi integrity and proteotoxicity in neurodegeneration. [PDF]
Xiang Q +10 more
europepmc +1 more source
[New results from the RABBIT register on the cancer risk of patients with rheumatoid arthritis treated with Janus kinase inhibitors]. [PDF]
Schäfer M, Strangfeld A.
europepmc +1 more source
[Systemic sclerosis : A disease with multiple faces]. [PDF]
Evers C, Distler J, Distler O.
europepmc +1 more source
Unveiling the Genetic Association Between Hemoglobin Concentration and Amyotrophic Lateral Sclerosis. [PDF]
Luo H, Yang Y, Cao X, Deng C, Chen H.
europepmc +1 more source
The Molecular Architecture of Neurodegeneration: An Integrative Overview of Convergent Mechanisms. [PDF]
Aranda-Abreu GE +5 more
europepmc +1 more source
Interactome screening implicates BAG6 as a suppressor of UBQLN2 misfolding in ALS/FTD. [PDF]
Kim SH +5 more
europepmc +1 more source

